Amid what it called an online barrage of “racist and stigmatizing language” about monkeypox, the World Health Organization said on Monday it will begin using a new preferred term “mpox” as a synonym for the disease.

CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC).

On November 28th China Biologics public release said that the company's anti-neoconazole monoclonal antibody F61 nasal spray developed by the company was approved for clinical use.

Liquid biopsy firm SeekIn said Monday that it has received a CE mark for its cancer recurrence monitoring test, SeekInCure, and is preparing to launch assay kits in the European Union and other countries that recognize the designation.

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

According to the WeChat public account of Peking Union Medical College Hospital on November 21, the peripheral blood cell image leukocyte assisted recognition software jointly developed by the Laboratory Department of Peking Union Medical College Hospital and Beijing Xiaofly Technology passed

Cue Health on Wednesday afternoon announced that revenues for the third quarter beat both Wall Street expectations and previous guidance from the firm.

DNAscope, a germline variant-calling pipeline from San Jose-based analytics firm Sentieon, achieved superior SNP and indel accuracy as compared to other standard datasets, according to a recent preprint from the company.

The 86th China International Medical Equipment Fair (CMEF) was suspended in consideration of the health and safety of all participants.

A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.

Avacta, a UK-based developer of cancer immunotherapies and diagnostics, said on Tuesday that it has signed an agreement to acquire Launch Diagnostics for up to ￡37 million ($41.9 million).

Lab testing supply firm Biocare Medical said Tuesday that it has acquired Empire Genomics, a provider of molecular probes for cancer research and diagnostics development, for an undisclosed amount.

The US Food and Drug Administration last week granted Emergency Use Authorization for Premier Medical Laboratory Services' Diversified Medical Healthcare SARS-CoV-2 Assay.

The COVID-19 Antigen Home Test manufactured by Assure Tech has been validated by laboratory and clinical studies to meet FDA standards and has been granted EUA. This means that the product can be marketed in the USA and in countries that recognise FDA EUA approval.

Meridian Bioscience reported on Tuesday that its fiscal fourth quarter revenues declined 14 percent year over year.